Cornelis Smit
0000-0002-1357-9248
13 papers found
Refreshing results…
Novel strategy to personalise use of ibuprofen for closure of patent ductus arteriosus in preterm neonates
Dosing Recommendations for Vancomycin in Children and Adolescents with Varying Levels of Obesity and Renal Dysfunction: a Population Pharmacokinetic Study in 1892 Children Aged 1–18 Years
Dose recommendations for gentamicin in the real-world obese population with varying body weight and renal (dys)function
Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties
Implications for IV posaconazole dosing in the era of obesity
Correction to: Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Nonobese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study
Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals
Fixed Dosing of Liposomal Amphotericin B in Morbidly Obese Individuals
Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Non-obese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study
A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients
Pharmacokinetics and probability of target attainment for micafungin in normal-weight and morbidly obese adults
Intravitreal aflibercept versus intravitreal ranibizumab in patients with age-related macular degeneration: a comparative effectiveness study
Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters
Missing publications? Search for publications with a matching author name.